Ж.Сарантуяа
Loading...
Товч нэр
Ж.Сарантуяа
Бүтэн нэр
Жав Сарантуяа
Латин нэр
Jav Sarantuya
Албан тушаал
Тэнхимийн эрхлэгч
Эрдмийн цол
Профессор
Боловсролын зэрэг
Доктор (Ph.D)
Харьяалал
3 results
Now showing 1 - 3 of 3
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Synergistic SNP-SNP interaction of NRG1 and ERBB4 increases the risk of schizophrenia(2025-09) ;Norovsambuu, Oyunchimeg; ; In last two decades, quite of few evidences were found about the genetic risk factor for schizophrenia. But until now, it's poorly understood that the pathogenesis of schizophrenia and contribution of those genetic factors in it. Inconsistent data reported for several candidate gene polymorphisms contributing on schizophrenia development, previously. The case-control study was conducted with 102 schizophrenia patients and 150 control subjects. HTR2A (rs6311), TPH2 (rs1386494), NRG1 (rs3924999 and rs2954041), DISC1 (rs821616 and rs6675281) and ERBB4 (rs7424835 and rs4673628) gene polymorphisms were detected by allele specific PCR and RFLP. Genetic analysis were performed by SNPAlyze 9.0 and STATA 13.0 software. Also, multidimensional regression analysis was used to determine the SNP-SNP interaction. T allele of rs821616 DISC1 and G allele of rs4673628 ERBB4, were associated with increased risk of schizophrenia. Significant difference was observed for heterozygous G/A genotype of rs6311 (G/A vs G/G + A/A, OR = 2.11; 95 % CI, 1.25-3.54, p = 0.005). By SNP-SNP interaction, the cumulative effect of NRG1 (rs3924999) and ERBB4 (rs4673628) combination, had increasing the risk of schizophrenia by 9.44-fold. This data require independent replication for rs821616, rs4673628 and rs6311 polymorphisms and schizophrenia risk. But particularity, our result suggests the interaction, rs3924999-rs4673628 of NRG1 and ERBB4 genes surprisingly increases the risk of schizophrenia.Scopus© Citations 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The polymorphisms of TSHR and CTLA-4 genes as genetic predictors of susceptibility to Graves` ophthalmopathy(Informa UK Limited, 2026-04); ; ; ; PURPOSE: To determine the genetic polymorphisms of CTLA-4 and TSHR genes with susceptibility to Graves` ophthalmopathy among patients with Graves' disease. METHODS: A total of 187 patients with Graves' disease were divided into two groups: 87 with Graves` ophthalmopathy and 100 without. Clinical examination and thyroid function tests were performed for all patients with Graves` disease. The genotyping was performed by restriction fragment length polymorphism and allele-specific PCR methods. RESULTS: rs5742909 T and rs1054708 T alleles were frequent in the group with Graves` ophthalmopathy. By genotypic comparison, the T/T and C/T genotypes of rs5742909 and the T/T genotype of rs1054708 were significantly higher among patients with Graves` ophthalmopathy. In addition, we found more than additive interaction between rs5742909 and rs1054708 (RERI = 3.787, AP = 0.122, S = 1.16), and the patients who carrying T/T or C/T of rs5742909 and T/T of rs1054708 had significantly higher risk of Graves` ophthalmopathy (aOR = 8.77, 95% CI = 3.02-25.52; Power = 98.1%). CONCLUSIONS: This result indicates that rs5742909 of CTLA-4 and rs1054708 of TSHR genes are the genetic risk factors for Graves` ophthalmopathy. In addition, the combination of these polymorphisms might be used as genetic predictors of Graves' ophthalmopathy. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The synergistic interaction between ACE and TMPRSS2 polymorphisms increases the risk of severe COVID-19(Public Library of Science (PLoS), 2026) ;Bayaraa, Odonchimeg; ; ; Within a few years after the pandemic outbreak, several of evidence have found to suggest that the genetic factors influence the severity and mortality rate of COVID-19. In particular, the identification of genetic markers that increase the risk of severe or critical COVID-19 is important for public health management during the pandemic. By August 2021, 88.9% of Mongolian population had been vaccinated. Therefore, we conducted this study to compare the polymorphisms of candidate genes by selecting people who developed mild or severe COVID-19 within this vaccinated population. A total of 90 patients with severe COVID-19, 95 patients with mild COVID-19, and 90 asymptomatic patients were participated in present cross-sectional study. rs4646994, rs4240157, rs41423247, rs56149945, rs10052957, rs12329760, rs4303795, rs75603675 and rs17854725 polymorphisms of the ACE, ACE2, NR3C1 and TMPRSS2 genes were genotyped. Genotyping performed by real-time PCR, RFLP and allele-specific PCR methods. Odds ratio, 95% confidence interval, p value were calculated using logistic regression analysis. SNP-SNP interaction were explored using multi-dimensional reduction analysis. P values for multivariate model was corrected by Bonferroni correction. Totally 10 polymorphisms of above-mentioned genes were genotyped among the groups. Only A/C genotype frequencies of rs75603675 were significantly different between groups. Compared with mild COVID-19 group, the participants who carrying A/C genotype of rs75603675 had 3.58-fold (95% CI, 1.38-9.29, p = 0.009) higher risk for severe COVID-19. In addition, the synergistic interaction (RERI = 2.573; AP = 0.934; S = 8.352) was observed between D/D or I/D genotype of rs4646994 and A/C genotype of rs75603675, which combination (OR=4.88, 95% CI, 1.38-18.01, p = 0.014, Power = 91.1%) was associated with increased risk of severe COVID-19 after Bonferroni correction. Our result suggesting that the combination of rs4646994 of the ACE gene and rs75603675 of the TMPRSS2 gene is associated with increased risk of severe COVID-19.
